Helder Pereira, Maria Inês Graça, Diana Fonseca, Alfredo Mendes-Castro, Fernando Abelha
{"title":"氯胺酮对腹腔镜术后恢复质量的影响:使用QoR-15问卷的单中心单盲试验","authors":"Helder Pereira, Maria Inês Graça, Diana Fonseca, Alfredo Mendes-Castro, Fernando Abelha","doi":"10.1155/2023/8890025","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The quality of recovery is a cluster of patient-related outcomes that emphasise not only pain but different physical and emotional dimensions. Traditionally, ketamine is used to improve postoperative analgesia and avoid opioid consumption and opioid-related side effects.</p><p><strong>Objective: </strong>The present study sought to evaluate if intraoperative ketamine administration (as a part of multimodal analgesia) influences the quality of recovery after laparoscopic surgery.</p><p><strong>Design: </strong>A prospective two-armed, single-blinded trial. <i>Settings</i>. Tertiary single-centre trial between July 2021 and January 2022. <i>Patients</i>. From the 146 patients initially admitted to the study, 127 patients were enrolled, 60 in the ketamine group (group K) and 67 in the control group (group NK). <i>Intervention</i>. Both groups received a rigid intraoperative anaesthesia protocol; furthermore, in group K, 0.5 mg/kg of the ideal body weight of ketamine was administered. <i>Main Outcome Measures</i>. The primary outcome was to evaluate the effect of ketamine administration on the postoperative quality of recovery using the Portuguese version of the Quality of Recovery-15 (QoR-15) Questionnaire 24 h after surgery. The total score and minimal clinically significant difference (MCID) of the QoR-15 were compared. Other variables were also assessed such as the presence of emergence delirium (ED), the Numeric Rating Scale (NRS) for pain, and the presence of postoperative nausea and vomiting (PONV).</p><p><strong>Results: </strong>A total of 127 patients were allocated to the study groups, 60 in group K and 67 in group NK. Regarding the primary outcome, no differences were found in individual categories (15 items) and in the total score of QoR-15 (<i>p</i>=0.214). Concerning improvement (MCID ≥ 8) or worsening (MCID ≤ 8) in quality of recovery, no difference was found between the groups (24 vs. 32 and 6 vs. 6; <i>p</i>=0.776). Finally, no difference was found in secondary postoperative outcomes including ED (<i>p</i>=0.55), NRS (<i>p</i>=0.401), and PONV (<i>p</i>=0.55).</p><p><strong>Conclusion: </strong>In this study, the administration of ketamine in laparoscopic surgery had no impact on the quality of recovery 24 h after surgery. This trial is registered with NCT03724019.</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":"2023 ","pages":"8890025"},"PeriodicalIF":1.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883102/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Ketamine on Quality of Recovery after Laparoscopic Surgery: A Single-Centre Single-Blinded Trial Using the QoR-15 Questionnaire.\",\"authors\":\"Helder Pereira, Maria Inês Graça, Diana Fonseca, Alfredo Mendes-Castro, Fernando Abelha\",\"doi\":\"10.1155/2023/8890025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The quality of recovery is a cluster of patient-related outcomes that emphasise not only pain but different physical and emotional dimensions. Traditionally, ketamine is used to improve postoperative analgesia and avoid opioid consumption and opioid-related side effects.</p><p><strong>Objective: </strong>The present study sought to evaluate if intraoperative ketamine administration (as a part of multimodal analgesia) influences the quality of recovery after laparoscopic surgery.</p><p><strong>Design: </strong>A prospective two-armed, single-blinded trial. <i>Settings</i>. Tertiary single-centre trial between July 2021 and January 2022. <i>Patients</i>. From the 146 patients initially admitted to the study, 127 patients were enrolled, 60 in the ketamine group (group K) and 67 in the control group (group NK). <i>Intervention</i>. Both groups received a rigid intraoperative anaesthesia protocol; furthermore, in group K, 0.5 mg/kg of the ideal body weight of ketamine was administered. <i>Main Outcome Measures</i>. The primary outcome was to evaluate the effect of ketamine administration on the postoperative quality of recovery using the Portuguese version of the Quality of Recovery-15 (QoR-15) Questionnaire 24 h after surgery. The total score and minimal clinically significant difference (MCID) of the QoR-15 were compared. Other variables were also assessed such as the presence of emergence delirium (ED), the Numeric Rating Scale (NRS) for pain, and the presence of postoperative nausea and vomiting (PONV).</p><p><strong>Results: </strong>A total of 127 patients were allocated to the study groups, 60 in group K and 67 in group NK. Regarding the primary outcome, no differences were found in individual categories (15 items) and in the total score of QoR-15 (<i>p</i>=0.214). Concerning improvement (MCID ≥ 8) or worsening (MCID ≤ 8) in quality of recovery, no difference was found between the groups (24 vs. 32 and 6 vs. 6; <i>p</i>=0.776). Finally, no difference was found in secondary postoperative outcomes including ED (<i>p</i>=0.55), NRS (<i>p</i>=0.401), and PONV (<i>p</i>=0.55).</p><p><strong>Conclusion: </strong>In this study, the administration of ketamine in laparoscopic surgery had no impact on the quality of recovery 24 h after surgery. This trial is registered with NCT03724019.</p>\",\"PeriodicalId\":7834,\"journal\":{\"name\":\"Anesthesiology Research and Practice\",\"volume\":\"2023 \",\"pages\":\"8890025\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883102/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anesthesiology Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/8890025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesiology Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/8890025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:康复质量是一组与患者相关的结果,不仅强调疼痛,而且强调不同的身体和情绪维度。传统上,氯胺酮用于改善术后镇痛,避免阿片类药物的消耗和阿片类药物相关的副作用。目的:本研究旨在评估术中氯胺酮(作为多模式镇痛的一部分)是否影响腹腔镜手术后的恢复质量。设计:前瞻性双臂单盲试验。设置。2021年7月至2022年1月进行第三期单中心试验。病人。从最初纳入研究的146例患者中,有127例患者入组,氯胺酮组(K组)60例,对照组(NK组)67例。干预。两组均采用严格的术中麻醉方案;K组按理想体重0.5 mg/kg给予氯胺酮。主要结果测量。主要观察结果为术后24 h使用葡萄牙语版康复质量-15 (QoR-15)问卷评估氯胺酮给药对术后恢复质量的影响。比较QoR-15的总分和最小临床显著差异(MCID)。其他变量也被评估,如紧急谵妄(ED)的存在,疼痛的数值评定量表(NRS),以及术后恶心和呕吐(PONV)的存在。结果:共127例患者被分为两组,K组60例,NK组67例。在主要转归方面,各单项(15项)和QoR-15总分均无差异(p=0.214)。在恢复质量改善(MCID≥8)或恶化(MCID≤8)方面,两组间无差异(24 vs. 32, 6 vs. 6;p = 0.776)。最后,术后次要结局包括ED (p=0.55)、NRS (p=0.401)和PONV (p=0.55)均无差异。结论:本研究中,腹腔镜手术中氯胺酮的使用对术后24 h的恢复质量没有影响。该试验注册号为NCT03724019。
Impact of Ketamine on Quality of Recovery after Laparoscopic Surgery: A Single-Centre Single-Blinded Trial Using the QoR-15 Questionnaire.
Background: The quality of recovery is a cluster of patient-related outcomes that emphasise not only pain but different physical and emotional dimensions. Traditionally, ketamine is used to improve postoperative analgesia and avoid opioid consumption and opioid-related side effects.
Objective: The present study sought to evaluate if intraoperative ketamine administration (as a part of multimodal analgesia) influences the quality of recovery after laparoscopic surgery.
Design: A prospective two-armed, single-blinded trial. Settings. Tertiary single-centre trial between July 2021 and January 2022. Patients. From the 146 patients initially admitted to the study, 127 patients were enrolled, 60 in the ketamine group (group K) and 67 in the control group (group NK). Intervention. Both groups received a rigid intraoperative anaesthesia protocol; furthermore, in group K, 0.5 mg/kg of the ideal body weight of ketamine was administered. Main Outcome Measures. The primary outcome was to evaluate the effect of ketamine administration on the postoperative quality of recovery using the Portuguese version of the Quality of Recovery-15 (QoR-15) Questionnaire 24 h after surgery. The total score and minimal clinically significant difference (MCID) of the QoR-15 were compared. Other variables were also assessed such as the presence of emergence delirium (ED), the Numeric Rating Scale (NRS) for pain, and the presence of postoperative nausea and vomiting (PONV).
Results: A total of 127 patients were allocated to the study groups, 60 in group K and 67 in group NK. Regarding the primary outcome, no differences were found in individual categories (15 items) and in the total score of QoR-15 (p=0.214). Concerning improvement (MCID ≥ 8) or worsening (MCID ≤ 8) in quality of recovery, no difference was found between the groups (24 vs. 32 and 6 vs. 6; p=0.776). Finally, no difference was found in secondary postoperative outcomes including ED (p=0.55), NRS (p=0.401), and PONV (p=0.55).
Conclusion: In this study, the administration of ketamine in laparoscopic surgery had no impact on the quality of recovery 24 h after surgery. This trial is registered with NCT03724019.